Therapeutic effect of systemic use of glatiramer acetate in imiquimod-induced mouse psoriasis model
Among the doses tested, 50 mcg GA administered after model induction was the most effective in reducing clinical severity and inflammatory cytokine expression. These findings suggest that GA is a promising systemic therapeutic agent for psoriasis.
Authors
- Melih Akyol (ORCID: https://orcid.org/0000-0001-7912-0651)
- Rukiye Yasak Güner (ORCID: https://orcid.org/0000-0002-5154-4652)
- Mustafa Tosun (ORCID: https://orcid.org/0000-0002-5204-2099)
- Goknur Demiran
- Mustafa Ozkara
Institutions
- Sivas Cumhuriyet Üniversitesi (TR)
- State Hospital (GB)
Publication Details
- Journal
- Cutaneous and Ocular Toxicology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/15569527.2025.2496638
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00